What this study is
The purpose of this clinical trial is to evaluate the level of comfort adult patients with cirrhosis of the liver and ascites presenting to Northwestern Memorial Hospital experience during a bedside abdominal paracentesis by numbing the skin with a needle-less device (the J-Tip), instead of using a needle to numb the skin. The main questions it aims to answer are the J-Tip effect upon:
1. Pain during intra-dermal local anesthetic administration 2. Pain during subcutaneous local anesthetic administration 3. Pain during paracentesis 4. Procedure-related anxiety
Participants will be randomly assigned to have their skin numbed either in the usual way with a needle or with the J-Tip. Participants will be responsible for having a paracentesis done in their hospital room and answering the survey questions regarding pain experienced during the procedure and how they would feel if they needed to have this procedure performed again. There is also a telephone follow-up survey 2 days after the procedure to ask the participant about their experience post-procedure. We will also collect data about any procedure complications.
What's being tested
- Experimental J-Tip Needle-Free Injection System
Intervention · DEVICE
This experimental intervention arm will include use of the J-Tip needle-less device to administer a one-time dose of 1% lidocaine during the superficial (intradermal) numbing step of a bedside abdominal paracentesis for adults with cirrhosis of the liver and ascites requiring bedside paracentesis.
- Control (Standard treatment)
Intervention · DEVICE
The control intervention arm will include use of a 25-gauge needle (standard of care) to administer a one-time dose of 1% lidocaine during the superficial (intradermal) numbing step of a bedside abdominal paracentesis for adults with cirrhosis of the liver and ascites requiring bedside paracentesis.
Study details
- Official title
- Use of the J-Tip Needle-Free Injection System With 1% Lidocaine to Reduce Paracentesis-Related Discomfort
- Sponsor
- Northwestern University
- Conditions
- Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin
- Enrolling
- 110 people
- Starts
- 2025-05-20
- Est. completion
- 2027-05
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Adult (age > 18 years) patients in the emergency department or admitted to the general medical service at Northwestern Memorial Hospital who:
- Have cirrhosis and ascites
- Require diagnostic and/or therapeutic paracentesis as determined by their primary physician
- Have capacity as determined by their ED or inpatient provider to consent for the procedure c. Speak English as a preferred language
You can't join if
- Have ever received chemotherapy, as this is a contra-indication to J-Tip use
- Lack capacity to consent for the procedure and/or capacity to rate their pain using the numeric pain rating scale
- Have a contraindication to bedside paracentesis, including:; Procedure deemed unsafe due to insufficient ascites/suboptimal location of ascites as evaluated by ultrasound; Cellulitis overlying the site of aspiration; Pregnancy
- Do not speak English as a preferred language
- Are prisoners
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openNorthwestern Memorial Hospital
Chicago, Illinois, United States
- Emily Kahn, MD · Contact(312) 926-5924emily.kahn@nm.org
- Christina Wing, BS · Contact(312) 926-0042christina.wing@northwestern.edu
- Emily Kahn, MD · Principal investigator
- Jeff Barsuk, MD, MS · Sub-investigator
- Kenzie A Cameron, PhD, MPH · Sub-investigator
- Jane Kim, MS, M.Ed · Sub-investigator
Recruiting
Study team
Sponsor
Northwestern University
Study ID STU00222556
Principal investigator
Emily Kahn, MD
Northwestern University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.